# Lithium

NDC: 71656-072
Generic name: Lithium
Labeler / Manufacturer: Saptalis Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20240328

FDA application: ANDA217183

## Active ingredients

- LITHIUM CITRATE: 8 meq/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71656-072"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71656-072
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e95036c7-542a-437a-969b-f95f6f949f84